StockData
Apimeds Pharmaceuticals US, Inc. logo

Apimeds Pharmaceuticals US, Inc. (APUS) stock

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$1.89−0.06 (-3.08%)

Close on Nov 18, 2026Market cap $2.85MP/E –Yield –

Apimeds Pharmaceuticals US gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.84M–

More Apimeds Pharmaceuticals US figures

See a number that looks wrong?